Upcoming Programs

    • 30 July
      Thursday
    • Subject01: Bispecific antibodies in relapsed multiple myeloma: current landscape and future directions Subject02: CAR-T cell therapy in ALL
      Speaker: Dr. Aditya Jandial Dr. Ashish Bajel
    • 06:30 PM Onwards
    • Join Webinar
      Brochure
    • 06 August
      Thursday
    • Subject01: JAK2 negative Erythrocytosis Subject02: From Evidence to Excellence: Integrating Zanubrutinib into Practice Subject03: Panel Discussion
      Speaker: Dr. Neeraj Arora Dr. Nitin Sood Dr. M. B. Agarwal
    • 06:30 PM Onwards
    • Register Now
      Brochure
    • 07 August
      Friday
    • Subject01: EHA highlights - 2026 Subject02: Myeloproliferative neoplasm - an update from EHA 2026
      Speaker: Dr. Vishal Jayakar Dr. Naseema Gangat
    • 06:30 PM Onwards
    • Register Now
      Brochure
    • 13 August
      Thursday
    • Subject01: The Marrow Under Siege: Deciphering Cytopenias in Blood Disorders Subject02: BCMA directed therapies in early relapsed myeloma: How to choose?
      Speaker: Dr. Neha Kamble Dr. Samer Al Hadidi
    • 06:30 PM Onwards
    • Register Now
      Brochure
    • 20 August
      Thursday
    • Subject01: Redefining the goal in Hodgkin Lymphoma in the era of novel therapies Subject02:CELMoDs (the next-generation IMiDs)
      Speaker: Dr. Sairah Ahmed Dr. Rahul Banerjee
    • 06:30 PM Onwards
    • Register Now
      Brochure
    • 27 August
      Thursday
    • Subject01: Bispecific Antibodies and CAR-T in Hematologic Malignancies: Hype, Hope, or Here to Stay? Subject02: Zanubrutinib: The Next Chapter in BTK Inhibition Subject03: Panel Discussion
      Speaker: Dr. Sunit Lokwani Dr. Anusha Swaminathan Dr. M. B. Agarwal
    • 06:30 PM Onwards
    • Register Now
      Brochure
Event Partner

www.perfectsquare.co.in